Sponsor or institution

Clinical trials and research at General Hospital of Shenyang Military Region

• 31Clinical trials
• 8Countries

Newest trials

All recruiting trials (31)

• Individualized, non-drug prep to improve bowel cleaning for colonoscopy

  This trial tests whether an individualized non-pharmacological plan—plus tailored information framing—can improve bowel preparation quality for adults undergoing colonoscopy.

  Recruiting General Hospital of Shenyang Military Region · Shenyang, Liaoning · NCT07684716

• Repeated intravenous prourokinase for ischemic stroke with medium to large vessel occlusion within 4.5 hours

  This study tests whether giving an extra infusion of prourokinase after initial treatment helps restore blood flow in adults with acute ischemic stroke due to medium or large vessel blockages within 4.5 hours.

  Recruiting Phase 2 General Hospital of Shenyang Military Region · Shenyang, None Selected · NCT07550296

• Using Transcranial Doppler to Detect and Reduce Emboli During Carotid Stenting

  This trial will test whether using transcranial Doppler ultrasound during and after carotid artery stenting can detect and reduce tiny brain emboli in people aged 40 and older with severe internal carotid artery narrowing.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT07462546

• Remote arm‑cuff conditioning plus stent placement for symptomatic carotid narrowing

  This study tests whether regular remote limb ischemic conditioning after carotid artery stenting can lower major vascular events and improve outcomes for adults with symptomatic carotid artery narrowing.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT07412249

• Adding evolocumab to usual lipid-lowering care for acute pancreatitis caused by very high triglycerides

  This study will try adding evolocumab to standard lipid-lowering care for adults hospitalized with hypertriglyceridemia-induced acute pancreatitis to see if it lowers triglycerides faster and reaches target levels within a week.

  Recruiting General Hospital of Shenyang Military Region · Shenyang, Liaoning · NCT07388420

• Repeat tenecteplase for early ischemic stroke with medium or large vessel blockage

  This trial will try giving a second dose of the clot-busting drug tenecteplase to adults with ischemic stroke from medium or large vessel blockages who still have an occlusion one hour after the first dose and are within 4.5 hours of symptom onset.

  Recruiting Phase 2 General Hospital of Shenyang Military Region · Shenyang, Liaoning · NCT07375966

• Repeated IV tenecteplase for ischemic stroke within 3 hours of onset

  This test tries a second IV dose of tenecteplase in adults with acute ischemic stroke who do not improve one hour after the first dose to see if a repeat dose is safe and can help reopen the blocked vessel.

  Recruiting Phase 2 General Hospital of Shenyang Military Region · Shenyang, None Selected · NCT07375953

• Short-term intensive statin treatment to lower cholesterol after ischemic stroke

  This study will see if a short course of higher-dose statins quickly lowers cholesterol in adults who recently had an ischemic stroke or have significant arterial stenosis.

  Recruiting General Hospital of Shenyang Military Region · Shenyang, Liaoning · NCT07344610

• Deep neck lymphatic-to-vein surgery for Alzheimer's disease

  This trial will try a deep neck lymphatic-to-vein surgical procedure in people aged 50–80 with biomarker-confirmed mild cognitive impairment or mild-to-moderate Alzheimer's disease to see if it improves symptoms.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT07294885

• Tenecteplase combined with urinary kallidinogenase for acute ischemic stroke

  This trial tests whether adding urinary kallidinogenase to tenecteplase helps adults with acute ischemic stroke recover better when treated within 4.5 hours of symptom onset.

  Recruiting Phase 2 General Hospital of Shenyang Military Region · Shenyang · NCT07283159

• Long-term remote ischemic conditioning to protect the heart, brain, and kidneys in very-high-risk ASCVD

  We will try regular remote ischemic conditioning to see if it protects the heart, brain, and kidneys in adults over 40 with very-high-risk ASCVD.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT07270887

• Head-down positioning before clot removal for large-vessel ischemic stroke.

  This trial will test whether placing adults with large-vessel ischemic stroke in a head-down position before endovascular clot removal helps protect brain tissue and improve recovery.

  Recruiting General Hospital of Shenyang Military Region · Shenyang, None Selected · NCT07172789

• IV tirofiban given before clot removal for anterior large-vessel ischemic stroke

  This trial will test whether giving IV tirofiban before endovascular clot removal helps people with anterior-circulation large-vessel ischemic stroke due to intracranial atherosclerosis.

  Recruiting Phase 3 General Hospital of Shenyang Military Region · Shenyang, Liaoning · NCT07135089

• Direct Ischemic Conditioning for Stroke Treatment

  This study is testing a new method called Direct Ischemic Conditioning to see if it can help improve recovery for stroke patients who have had a blocked blood vessel treated.

  Recruiting General Hospital of Shenyang Military Region · Shengyang, Liaoning · NCT06940128

• Using remote ischemic conditioning to treat acute moderate posterior ischemic stroke

  This study is testing if a new treatment called remote ischemic conditioning can help people who have had an acute moderate posterior ischemic stroke recover better in the days following their stroke.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT06931535

• Treating acute drug-induced liver injury with high bilirubin using steroids

  This trial will test whether adding glucocorticoid (steroid) treatment to standard care helps adults with acute drug‑induced liver injury and high bilirubin recover faster and avoid worsening liver problems.

  Recruiting General Hospital of Shenyang Military Region · Shenyang, Liaoning · NCT06922669

• Balloon angioplasty for patients with minor strokes caused by narrowed brain arteries

  This study is testing if a procedure called balloon angioplasty can help people who have had minor strokes from narrowed brain arteries feel better and prevent more strokes.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT06763458

• Human albumin for overt hepatic encephalopathy in liver cirrhosis

  This research will test whether different doses of human albumin help adults with liver cirrhosis and overt hepatic encephalopathy regain mental function sooner.

  Recruiting General Hospital of Shenyang Military Region · Shenyang, Liaoning · NCT06483737

• Using glucocorticoids to treat intestinal injury from radiation

  This study is testing if glucocorticoids can help patients who have intestinal injuries from radiation treatment feel better compared to standard care.

  Recruiting General Hospital of Shenyang Military Region · Shenyang, Liaoning · NCT06410443

• Examining blood markers after treatment for severe strokes

  This study is testing if certain blood markers can help doctors understand how well patients with severe strokes are doing after they receive a specific treatment.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT06383182

• Exploring the effects of remote ischemic preconditioning on stroke recovery

  This study is testing if a special treatment called remote ischemic preconditioning can help improve blood flow and recovery in stroke patients with poor circulation after their stroke.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT06170944

• Using head-down position for treating acute ischemic stroke

  This study is testing if lying in a head-down position can help adults with acute ischemic stroke caused by large artery blockages recover better.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT06010641

• Using Tenecteplase for Stroke Treatment Between 4.5 to 6 Hours After Onset

  This study is testing if a medication called tenecteplase can help people who have had a stroke between 4.5 to 6 hours after their symptoms started.

  Recruiting at 2 sites Phase 4 General Hospital of Shenyang Military Region · Shenyang, None Selected and 1 other locations · NCT06010628

• Using high-resolution MRI to study brain artery plaques in stroke patients

  This study is testing how high-resolution MRI can help understand the plaque in brain arteries of stroke patients to find better ways to prevent future strokes.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT05897645

• Using Fingolimod to treat Type 2 Diabetes

  This study is testing if Fingolimod can help people with Type 2 Diabetes manage their condition better than standard treatments.

  Recruiting Phase 4 General Hospital of Shenyang Military Region · Shenyang · NCT05307731

• Intra-arterial neuroprotection for ischemic stroke patients who missed reperfusion therapy

  This study will try giving neuroprotective medicine directly into an artery to help adults with acute ischemic stroke who missed clot-opening treatment or whose symptoms worsened.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT04664946

• Neuroprotective treatment for patients with ischemic stroke undergoing endovascular therapy

  This study is testing a new treatment that delivers protective medicine directly into the arteries of stroke patients during a procedure to see if it helps them recover better and reduces brain damage.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT04664933

• Evaluating a new scoring system for predicting mortality in cirrhotic patients with gastrointestinal bleeding

  This study is testing a new scoring system to see if it can better predict the risk of death in adults with liver cirrhosis who are having gastrointestinal bleeding.

  Recruiting at 19 sites General Hospital of Shenyang Military Region · Scranton, Pennsylvania and 22 other locations · NCT04662918

• Improving treatment for ischemic stroke with poor blood flow after thrombectomy

  This study is testing whether giving a medication called tenecteplase after a procedure to remove a blood clot can help improve blood flow in stroke patients who didn't get enough recovery from the treatment.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT04201964

• Intensive statin therapy for ischemic stroke with intracranial atherosclerotic plaques

  This study is testing whether stronger doses of statin medication can help people who have had an ischemic stroke due to plaque buildup in their brain arteries.

  Recruiting Phase 4 General Hospital of Shenyang Military Region · Shenyang · NCT03753555

• Investigating the effects of anti-thrombosis on brain microbleeds in stroke patients

  This study is testing whether blood-thinning medications affect the risk of new brain microbleeds in stroke patients.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT03571763

Quick answers

How many clinical trials run by General Hospital of Shenyang Military Region are recruiting right now?

31, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 8 countries. The most sites are in China (31 trials), Brazil (1 trial), Germany (1 trial), India (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 4: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →